Pilot Study of Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer - Trial NCT06409390
Access comprehensive clinical trial information for NCT06409390 through Pure Global AI's free database. This Phase 1 trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute and is currently Recruiting. The study focuses on Metastatic Breast Cancer. Target enrollment is 15 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
H. Lee Moffitt Cancer Center and Research Institute
Timeline & Enrollment
Phase 1
May 01, 2024
Apr 01, 2027
Primary Outcome
Feasibility of Sequential Therapy
Summary
The purpose of the study is to test a treatment strategy with currently approved drugs to see
 if it is practical to administer the available drugs in a new way that researchers hope could
 be more effective in treating metastatic breast cancer.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06409390
Non-Device Trial